Although STAT3 and STAT5B mutations are present in a significant percentage of all LGLL patients, their clinical and biological significance remain to be (fully) established [18,19,20,21,24,26,29,31,33]. Here, STAT3 is linked to T-cell large granular lymphocyte leukemia.